Literature DB >> 15693801

Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis.

Leonidas Benetatos, Benetatos Leonidas, Aristeidis Chaidos, Chaidos Aristeidis, Vasiliki Alymara, Alymara Vasiliki, Amalia Vassou, Vassou Amalia, Konstantinos L Bourantas, Bourantas L Konstantinos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15693801     DOI： 10.1111/j.1600-0609.2004.00386.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  2 in total

1.  Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis.

Authors:  Lucia Masarova; Ahmad Alhuraiji; Prithviraj Bose; Naval Daver; Naveen Pemmaraju; Jorge Cortes; Sherry Pierce; Hagop Kantarjian; Srdan Verstovsek
Journal:  Eur J Haematol       Date:  2018-01-17       Impact factor: 2.997

Review 2.  Conventional and experimental drug therapy in myelofibrosis with myeloid metaplasia.

Authors:  Ruben A Mesa; Alfonso Quintás-Cardama; Srdan Verstovsek
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 4.213
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.